EP3230316

BAYER HEALTHCARE
Application Number
EP15819965A
Filing Date
Dec 10, 2015
Status
Granted And Under Opposition
Dec 3, 2021
Grant Date
Jan 5, 2022
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Biblio Summary

The patent EP3230316B1 was granted on Jan 5, 2022 by Bayer Healthcare The patent is currently Granted And Under Opposition.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

AMGENOct 5, 2022ADMISSIBLE
BOEHMERT & BOEHMERT ANWALTSPARTNERSCHAFT MBBOct 5, 2022ADMISSIBLE
BOULT WADE TENNANTOct 5, 2022ADMISSIBLE
MAIWALDOct 5, 2022ADMISSIBLE
WITHERS & ROGERSOct 4, 2022ADMISSIBLE
WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBBOct 4, 2022ADMISSIBLE

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionWO2016094673
N/A

Access Full Citation Information

Get a free, in-depth citation report including examiner, opposition, and international search citations.

Get Free Citation Report

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.